Oswaldo Cruz Foundation (Fiocruz) is Brazil’s leading public science and technology institution in health. Founded in 1900 and linked to the Ministry of Health, it is headquartered in Rio de Janeiro and operates a nationwide network of research, clinical, and reference laboratories serving the country’s Unified Health System (SUS).
Fiocruz conducts research and innovation in biomedical and public health sciences and produces health technologies at industrial scale. Through units such as Bio-Manguinhos and Farmanguinhos, it develops and manufactures vaccines, biopharmaceuticals, diagnostic kits, and essential medicines, and provides quality control and regulatory reference services. The foundation also supports epidemiological surveillance, delivers specialized healthcare, and offers graduate education and workforce training. Fiocruz collaborates with national and international partners, including multilateral health agencies, to advance access to immunobiologicals and other strategic health products.